|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Personal history of malig neoplasm of bone and soft tissue
ICD-10 (CM) Code and Descriptor
|
Z85.830 |
Personal history of malignant neoplasm of bone
This code is considered unacceptable as a principal diagnosis.
|
Z85830 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 3.82%
|
12.88%
|
12.50%
|
11.39%
|
10.49%
|
8.48%
|
7.41%
|
6.46%
|
4.93%
|
4.27%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z85.830*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
349
|
349
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
84
|
84
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
80
|
80
|
|
80053
|
COMPREHEN METABOLIC PANEL |
71
|
71
|
|
71260
|
CT THORAX DX C+ |
51
|
51
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
51
|
5,290
|
|
71250
|
CT THORAX DX C- |
50
|
50
|
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
46
|
46
|
|
73552
|
X-RAY EXAM OF FEMUR 2/> |
43
|
43
|
|
82565
|
ASSAY OF CREATININE |
36
|
36
|
|
G1004
|
CDSM NDSC |
36
|
40
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
26
|
26
|
|
A9585
|
GADOBUTROL INJECTION |
24
|
1,880
|
|
73590
|
X-RAY EXAM OF LOWER LEG |
21
|
21
|
|
73560
|
X-RAY EXAM OF KNEE 1 OR 2 |
20
|
20
|
|
72197
|
MRI PELVIS W/O & W/DYE |
20
|
20
|
|
A9575
|
INJ GADOTERATE MEGLUMI 0.1ML |
20
|
2,725
|
|
97110
|
THERAPEUTIC EXERCISES |
19
|
37
|
|
84100
|
ASSAY OF PHOSPHORUS |
19
|
19
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
18
|
18
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z85.830 related to the following DRG Codes:
826-828
829-830
843-845
|
